Edition:
United States

Takeda Pharmaceutical Co Ltd (TKPYY.PK)

TKPYY.PK on OTC Markets Group

22.34USD
26 Aug 2016
Change (% chg)

$-0.18 (-0.80%)
Prev Close
$22.52
Open
$22.40
Day's High
$22.63
Day's Low
$22.22
Volume
40,775
Avg. Vol
54,572
52-wk High
$25.72
52-wk Low
$20.32

TKPYY.PK

Chart for TKPYY.PK

About

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases,... (more)
No analyst recommendations are available for TKPYY.PK.

Overall

No Ratios Available.

Financials

  TKPYY.PK Industry Sector
P/E (TTM): -- 36.93 36.63
EPS (TTM): -- -- --
ROI: -- 14.69 14.12
ROE: -- 15.48 15.04

Toshiba Medical joins bid to by Takeda unit: Nikkei

TOKYO Toshiba Medical Systems, a medical equipment company that is being bought by Canon Inc , joined a race to buy a subsidiary of Takeda Pharmaceutical Co , the Nikkei business daily reported on Friday.

Aug 18 2016

Toshiba Medical joins bid to by Takeda unit-Nikkei

TOKYO, Aug 19 Toshiba Medical Systems, a medical equipment company that is being bought by Canon Inc, joined a race to buy a subsidiary of Takeda Pharmaceutical Co , the Nikkei business daily reported on Friday.

Aug 18 2016

BRIEF-Toshiba Medical Systems has made an offer to buy Takeda's unit Wako Pure Chemicals Industries - Nikkei

* Toshiba Medical Systems has made an offer to acquire a Takeda Pharmaceutical subsidiary - Nikkei

Aug 18 2016

BRIEF-Hitachi Group has elbowed into a race to acquire Takeda Pharmaceutical's unit with Fujifilm Holdings - Nikkei

* The Hitachi Group has elbowed into a race to acquire a Takeda Pharmaceutical Subsidiary, raising the prospect of a bidding war with Fujifilm Holdings - Nikkei

Aug 16 2016

Deals of the day- Mergers and acquisitions

July 26 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

Jul 26 2016

Takeda sets bidding deadline for chemical firm stake, CVC and Carlyle may bid -sources

TOKYO, July 26 Takeda Pharmaceutical Co Ltd will accept initial bids for its 70 percent stake in a chemicals company through Aug. 16, with potential suitors including CVC Capital Partners Ltd and Carlyle Group Ltd, sources told Reuters.

Jul 26 2016

BRIEF-Fujifilm to bid for Takeda's research reagents unit - Nikkei

* Fujifilm Holdings is set to make an offer for a laboratory chemicals unit of Takeda Pharmaceutical - Nikkei

Jul 21 2016

Court dismisses Takeda's bid to block Hikma gout drug sales

By Brendan Pierson A federal appeals court has dismissed a bid by Takeda Pharmaceutical Co to halt sales of Hikma Pharmaceuticals PLC's gout drug Mitigare, which has the same active ingredient as Takeda's Colcrys.

Jul 15 2016

BRIEF-Takeda receives EC approval of adcetris for post-transplant hodgkin lymphoma

* Takeda receives European Commission approval of adcetris (brentuximab vedotin) for consolidation treatment in post-transplant hodgkin lymphoma Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Jul 06 2016

BRIEF-Takeda Pharmaceutical, Altos Therapeutics to develop Altos's ATC-1906

* Co, Altos Therapeutics have entered into agreement to further development of Altos's proprietary compound ATC-1906

Jul 01 2016

Earnings vs. Estimates

No consensus analysis data available.